Literature DB >> 23960843

Pharmaceutical policies used by private health insurance companies in Saudi Arabia.

Saleh A Bawazir1, Mohammed A Alkudsi, Abdullah S Al Humaidan, Maher A Al Jaser, Larry D Sasich.   

Abstract

BACKGROUND: Currently, the Council of Cooperative Health Insurance (CCHI) is the body responsible for regulating health insurance in the KSA. While the cooperative health insurance schedule (i.e., model policy for health insurance) is available on the CCHI web site, policies related to pharmaceuticals are ambiguous. AIMS: The primary objective of this study was to assess the impact of health insurance policies provided by health insurance companies in KSA on access to medication and its use. SETTINGS AND
DESIGN: This study was descriptive in design and used a survey, which was conducted through face-to-face interviews with the medical managers of health insurance companies. METHODS AND MATERIAL: The survey took place between March and June, 2011. All 25 insurance companies accredited by CCHI were eligible to be included in the study. Out of these 25 companies, three were excluded from this survey as no response was received.
RESULTS: All the 16 companies responded "Yes" that they had a prior authorization policy; however, their reasons varied. Eight (50%) of the companies were concerned about the duration of treatment. While 10 (62.5%) did not offer additional coverage over the CCHI model policy, the other 6 (37.5%) reported that they could reconcile certain conditions. The survey also demonstrated that 10 insurance companies allowed refilling of medication but with certain limitations. Six out of the 10 permitted refilling within a maximum time of three months, whereas the other four companies did not have any time-based limits for refilling. The other six companies did not allow refilling without prescription.
CONCLUSIONS: Although this paper was primarily descriptive, the findings revealed a substantial scope for improvement in terms of pharmaceutical policy standards and regulation in the health insurance companies in KSA. Additionally, the study highlighted such areas to augment the overall quality use of medication, over-prescribing and irrational use of medication. Further research, thus, is definitely needed.

Keywords:  Delivery of health care; Health care policy; Health insurance; Saudi Arabia

Year:  2012        PMID: 23960843      PMCID: PMC3744982          DOI: 10.1016/j.jsps.2012.10.005

Source DB:  PubMed          Journal:  Saudi Pharm J        ISSN: 1319-0164            Impact factor:   4.330


  11 in total

1.  Access to care and medicines, burden of health care expenditures, and risk protection: results from the World Health Survey.

Authors:  Anita K Wagner; Amy Johnson Graves; Sheila K Reiss; Robert Lecates; Fang Zhang; Dennis Ross-Degnan
Journal:  Health Policy       Date:  2010-09-09       Impact factor: 2.980

2.  How health insurance design affects access to care and costs, by income, in eleven countries.

Authors:  Cathy Schoen; Robin Osborn; David Squires; Michelle M Doty; Roz Pierson; Sandra Applebaum
Journal:  Health Aff (Millwood)       Date:  2010-11-18       Impact factor: 6.301

Review 3.  Active pharmaceutical management strategies of health insurance systems to improve cost-effective use of medicines in low- and middle-income countries: a systematic review of current evidence.

Authors:  Laura Faden; Catherine Vialle-Valentin; Dennis Ross-Degnan; Anita Wagner
Journal:  Health Policy       Date:  2010-12-24       Impact factor: 2.980

4.  Prescribing patterns of ambulatory care physicians in Saudi Arabia.

Authors:  S A Bawazir
Journal:  Ann Saudi Med       Date:  1993-03       Impact factor: 1.526

5.  Obesity in Saudi Arabia.

Authors:  Mansour M Al-Nozha; Yaqoub Y Al-Mazrou; Mohammed A Al-Maatouq; Mohammed R Arafah; Mohamed Z Khalil; Nazeer B Khan; Khalid Al-Marzouki; Moheeb A Abdullah; Akram H Al-Khadra; Saad S Al-Harthi; Maie S Al-Shahid; Abdulellah Al-Mobeireek; Mohmmed S Nouh
Journal:  Saudi Med J       Date:  2005-05       Impact factor: 1.484

6.  Medicare part D research and policy highlights, 2012: impact and insights.

Authors:  Denys T Lau; JoAnn Stubbings
Journal:  Clin Ther       Date:  2012-03-13       Impact factor: 3.393

Review 7.  Medicare Part D and quality of prescription medication use in older adults.

Authors:  Denys T Lau; Becky A Briesacher; Daniel R Touchette; JoAnn Stubbings; Judy H Ng
Journal:  Drugs Aging       Date:  2011-10-01       Impact factor: 3.923

Review 8.  The morbidity and mortality associated with overweight and obesity in adulthood: a systematic review.

Authors:  Matthias Lenz; Tanja Richter; Ingrid Mühlhauser
Journal:  Dtsch Arztebl Int       Date:  2009-10-02       Impact factor: 5.594

9.  Sexually transmitted infections in Saudi Arabia.

Authors:  Tariq A Madani
Journal:  BMC Infect Dis       Date:  2006-01-10       Impact factor: 3.090

10.  The changing face of healthcare in Saudi Arabia.

Authors:  Stephen Walston; Yousef Al-Harbi; Badran Al-Omar
Journal:  Ann Saudi Med       Date:  2008 Jul-Aug       Impact factor: 1.526

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.